New Zealand markets closed

Qyuns Therapeutics Co., Ltd. (2509.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
28.300-0.400 (-1.39%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
364,404
364,404
257,214
151,887
Selling general and administrative
164,594
164,594
76,603
23,985
Total operating expenses
515,402
515,402
324,623
180,713
Operating income or loss
-515,402
-515,402
-324,623
-180,713
Interest expense
16,821
16,821
18,692
17,842
Income before tax
-521,333
-521,333
-312,381
-426,544
Income tax expense
-73
-73
-73
-73
Income from continuing operations
-521,260
-521,260
-312,308
-426,471
Net income
-507,748
-507,748
-298,191
-411,039
Net income available to common shareholders
-507,748
-507,748
-298,191
-411,039
Basic EPS
-2.14
-
-1.34
-1.85
Diluted EPS
-2.14
-
-1.34
-1.85
Basic average shares
222,072
-
222,072
222,072
Diluted average shares
222,072
-
222,072
222,072